register

News - MedTech & Diagnostics

Cardinal Health international leader emphasises enhanced customer value through new go-to-market model

Health Industry Hub | October 23, 2023 |

MedTech & Diagnostics News: In an exclusive interview with Health Industry Hub, Jorge Sahlieh, President of International Medical Products and Distribution at Cardinal Health, delved into his two-decade-long journey in the healthcare, medical devices, and fast-moving consumer goods (FMCG) sectors, and the key milestones that have shaped his journey within the Cardinal Health.

The conversation then turned to the critical challenges and complexities that the healthcare ecosystem faces today. In his role, Mr Sahlieh underscored the significance of customer centricity, both in terms of patients and healthcare professionals (HCPs), in addressing these challenges. Reimagining healthcare is a paramount goal for the industry, and the discussion expanded to the role of medtech companies like Cardinal Health in forging a path toward equitable access to healthcare services.

Over the last year, Cardinal Health has embarked on a transformative journey to enhance its operations guided by the principles of “focus and simplicity.” The interview delved into how this transformation is aligning with the evolving needs of the business and healthcare providers, ensuring streamlined operations and enhanced service delivery.

Looking ahead, Mr Sahlieh explored the top trends shaping the future of the medtech sector and how Cardinal Health is strategically aligning its business to thrive in this dynamic ecosystem. He offered valuable insights into the company’s forward-looking strategies and its commitment to staying at the forefront of the medtech industry.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - MedTech & Diagnostics

Roche unlocks new horizons for genomic research in Asia Pacific

Roche unlocks new horizons for genomic research in Asia Pacific

Health Industry Hub | November 9, 2026 |

Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in June […]

More


News - Pharmaceuticals

'Unexpected and Surprising': Novartis’ Lp(a) setback raises tough questions for Amgen and Lilly - Professor Stephen Nicholls, Victorian Heart Hospital

‘Unexpected and surprising’: Novartis Lp(a) setback raises tough questions for Amgen and Lilly

Health Industry Hub | November 9, 2026 |

The failure of Novartis’ lipoprotein(a) [Lp(a)] therapy to translate substantial biomarker reductions into meaningful cardiovascular benefits has been met with […]

More


News - MedTech & Diagnostics

More public hospitals turn to same-day hip and knee surgery but recovery risks persist

More public hospitals turn to same-day hip and knee surgery, but key blind spots persist

Health Industry Hub | November 9, 2026 |

Same-day hip and knee replacements to ease surgical waiting lists are being trialled at The Royal Adelaide Hospital (RAH), but […]

More


News - Pharmaceuticals

TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning

TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning

Health Industry Hub | November 9, 2026 |

The Therapeutic Goods Administration (TGA) approval of Novo Nordisk’s oral GLP-1 receptor agonist Wegovy (semaglutide) is introducing a new dimension to […]

More


This content is copyright protected. Please subscribe to gain access.